e-learning
resources
2018
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Sarcoidosis: patient treatment priorities
Robert P. Baughman, Rita Barriuso, Kelli Beyer, Jeanette Boyd, Johann Hochreiter, Chris Knoet, Filippo Martone, Bernd Quadder, Jack Richardson, Ginger Spitzer, Dominique Valeyre, Gianluca Ziosi
Source:
ERJ Open Res, 4 (4) 00141-2018; 10.1183/23120541.00141-2018
Journal Issue:
October
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Robert P. Baughman, Rita Barriuso, Kelli Beyer, Jeanette Boyd, Johann Hochreiter, Chris Knoet, Filippo Martone, Bernd Quadder, Jack Richardson, Ginger Spitzer, Dominique Valeyre, Gianluca Ziosi. Sarcoidosis: patient treatment priorities. ERJ Open Res, 4 (4) 00141-2018; 10.1183/23120541.00141-2018
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Emerging classes of drugs for the treatment of obstructive lung disease
Related content which might interest you:
Sarcoidosis treatment and outcomes: what is most important to patients?
Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes
Year: 2018
Sarcoidosis: principles of diagnosis
Source: Eur Respir Monogr 2022; 96: 57-74
Year: 2022
Understanding the priorities for women diagnosed with lymphangioleiomyomatosis: a patient perspective
Source: ERJ Open Res 2016: 00102-2015
Year: 2016
The future of treatment for interstitial lung diseases: the patient’s and physician’s perspective
Source: International Congress 2019 – Rare lung diseases
Year: 2019
Therapeutic strategies: what treatment for what patient
Source: Annual Congress 2008 - PG12 - Challenges in pulmonary embolism: hot issues and interactive cases (jointly organised with ACCP)
Year: 2008
Sarcoidosis: pulmonary manifestations and management
Source: Eur Respir Monogr 2019; 86: 404-418
Year: 2019
Subcutaneous sarcoidosis: A clinical analysis of nine patients
Source: International Congress 2015 – Sarcoidosis: clinical
Year: 2015
Multidisciplinary diagnosis of ILD: the radiologist’s perspective. Case presentations
Source: Virtual Congress 2021 – Imaging grand round
Year: 2021
Balancing treatment and side-effects in severe asthma: a patient and professional perspective
Source: Breathe, 17 (2) 210045; 10.1183/20734735.0045-2021
Year: 2021
International perspectives on severe asthma: Current and future challenges in patient care
Source: International Congress 2016 – Asthma points to ponder
Year: 2016
Managing tuberculosis in chronic kidney disease: An evaluation of patient treatment regimens
Source: Annual Congress 2011 - Tuberculosis in special populations
Year: 2011
Self-management in bronchiectasis: the patients' perspective
Source: Eur Respir J 2007; 29: 541-547
Year: 2007
The journey to bronchiectasis diagnosis and care: an EMBARC/ELF patient survey
Source: Virtual Congress 2021 – Bronchiectasis and pleural infection
Year: 2021
Diagnosis of fibrotic hypersensitivity pneumonitis: Can an algorithm replace multidisciplinary team discussion?
Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020
Advance care planning in life-threatening pulmonary disease: a focus group study
Source: ERJ Open Res, 4 (2) 00101-2017; 10.1183/23120541.00101-2017
Year: 2018
Challenges to travelling with a lung condition: a patient perspective
Source: International Congress 2017 – Air travel for respiratory patients
Year: 2017
Granulomatous lymphadenitis: Experience of a portuguese oncologic institute
Source: International Congress 2015 – Acute and chronic lung diseases: good clinical practice
Year: 2015
Sarcoidosis: Changed phenotype and worsening of the course by overtime
Source: International Congress 2015 – Acute and chronic lung diseases: good clinical practice
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept